AdvanCell

id 10343
name AdvanCell
category_id 9
sector_or_kind Biotech / Pharma
sector_slug biotech_pharma
parent_category_id 1
parent_kind Operating Company
parent_kind_slug operating_company
classification_tier
classification_confidence
hq_city
hq_country US
description AdvanCell, a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, received a $315 million Series D ...
tenant_id 1